Aims: Evaluation of Anti-asthmatic Potential of Quercetin Nanocrystals in BALB/c Mice.
Discussion:
In this study, we have successfully demonstrated the enhanced bioavailability, solubility and counteractive efficiency of quercetin by synthesized quercetin nanocrystals (nQ). Further, effect of nQ has been established by studying the pharmacokinetics, stability as well as anti-asthmatic property in the OVA induced allergic asthma mice. More importantly, mast cells, one of the significant pathological features of asthma, were found to be decreased by nQ leading to diminished asthma symptoms. The present study indicate that nQ alleviate pulmonary inflammation and airway hyporesponsiveness in allergic asthma at much lower dose compared to bulk quercetin and may be considered as a potential drug for the treatment of asthmatic patients.
Conclusion:
In conclusion, the prepared water soluble quercetin nanocrystals have shown potential as promising nanovehicle with in vivo and ex vivo stability, excellent bioavailability, and therapeutic efficacy in asthma murine model. It has also been found to be effective in preventing anaphylaxis in murine model of allergic asthma. In totality, the nQ has potential to substantially reduce the symptoms of asthma and may play an important role in providing the most effective cure for asthma that is currently lacking. 
